Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
Correlation Between Fibroscan, Liver Biopsy, and Clinical Liver Function in Patients With Hepatitis C Virus Infection After Renal Transplantation
Transplantation Proceedings, 09/16/09
Munoz R et al. – Among renal transplant patients with HCV the values of Fibroscan seem to correlate with the degree of fibrosis by biopsy and with clinical liver function. Therefore, Fibroscan may be useful to follow patients with LD. However, these results should be analyzed with caution due to the small number of cases and retrospective nature of the study.
Related Articles
Allogeneic hematopoietic stem cell transplantation (alloSCT) for chronic myeloid leukemia in the imatinib era; Evaluation of its impact within a subgroup of the randomized German CML Study IV
Blood, 11/20/09
Relevance Score: 94%
Aerosolized vancomycin for the treatment of MRSA after lung transplantation
Respirology, 11/10/09
Relevance Score: 94%
Pre-transplant lung function is predictive of survival following pediatric bone marrow transplantation
Pediatric Blood & Cancer, 11/05/09
Relevance Score: 94%
Soluble CD30 Levels in Recipients Undergoing Heart Transplantation Do Not Predict Post-transplant Outcome
The Journal of Heart and Lung Transplantation, 10/28/09
Relevance Score: 94%
Fulminant Hepatic Failure due to Varicella Zoster in a Heart Transplant Patient: Successful Liver Transplant
The Journal of Heart and Lung Transplantation, 10/28/09
Relevance Score: 93%
Today in Hepatitis...keeping you current
Receive free subspecialty "5-minute updates" via email
Different models of HBeAg seroconversion predicated by on-treatment ALT and HBV DNA profiles
Journal of Viral Hepatitis, 11/25/09
Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCV/HIV-coinfected patients with an undetectable HCV viral load at week 4 of peginterferon-alfa-2a/ribavirin therapy
Journal of Viral Hepatitis, 11/25/09
Mutation frequency of NS5A in patients vertically infected with HCV genotype 1 predicts sustained virological response to peginterferon alfa-2b and ribavirin combination therapy
Journal of Viral Hepatitis, 11/25/09
Article Search
Sponsor


See Latest Articles


